| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 16, 2024 | Option Exercise | $36.10 | 5,601 | 202,196 | 15,480 | Feb 20, 2024, 06:53 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 15, 2024 | Option Exercise | $35.91 | 686 | 24,634 | 10,659 | Feb 16, 2024, 05:41 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 10, 2024 | Option Exercise | $35.49 | 1,477 | 52,419 | 10,091 | Feb 13, 2024, 04:15 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 16, 2023 | Sale | $49.26 | 2,525 | 124,381 | 9,066 | Feb 21, 2023, 07:00 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 15, 2023 | Option Exercise | $49.20 | 621 | 30,553 | 6,497 | Feb 17, 2023, 06:25 AM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 10, 2023 | Option Exercise | $48.92 | 1,392 | 68,097 | 5,156 | Feb 14, 2023, 05:21 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 12, 2023 | Option Exercise | $48.92 | 681 | 33,315 | 5,864 | Feb 14, 2023, 05:21 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Nov 15, 2022 | Sale | $53.81 | 5,000 | 269,053 | 4,410 | Nov 16, 2022, 07:51 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 15, 2022 | Option Exercise | $34.43 | 433 | 14,908 | 9,045 | Feb 17, 2022, 06:03 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 10, 2022 | Option Exercise | $34.94 | 1,025 | 35,813 | 6,511 | Feb 14, 2022, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 12, 2022 | Option Exercise | $34.20 | 506 | 17,305 | 7,394 | Feb 14, 2022, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 14, 2022 | Option Exercise | $33.64 | 427 | 14,364 | 8,223 | Feb 14, 2022, 07:28 PM |
Menu